Evidence map›Paper›PMID 35496049›Full record

ArticleBioMed research international2022

Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice.

Mohammed Alorabi, Doha Saad Mohammed, Gomaa Mostafa-Hedeab, Suzy A El-Sherbeni, Walaa A Negm, Ali Ismail A Mohammed, Hayder M Al-Kuraishy, Nani Nasreldin, Saqer S Alotaibi, Bashir Lawal and 2 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 5 countries.

Mohammed AlorabiDepartment of Biotechnology, College of Sciences, Taif University, P.O.Box 11099, Taif 21944, Saudi Arabia.
Doha Saad MohammedDepartment of Clinical Pharmacology, College of Medicine, University of Al-Mustansiriyah, Iraq.
Gomaa Mostafa-HedeabPharmacology Department & Health Research Unit, Medical College, Jouf University, Jouf, Saudi Arabia.ORCID https://orcid.org/0000-0003-4947-0495
Suzy A El-SherbeniDepartment of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt.
Walaa A NegmDepartment of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt.
Ali Ismail A MohammedDepartment of Clinical Pharmacology, College of Medicine, University of Al-Mustansiriyah, Iraq.
Hayder M Al-KuraishyDepartment of Clinical Pharmacology, College of Medicine, University of Al-Mustansiriyah, Iraq.
Nani NasreldinDepartment of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, New Valley University, El-Kharga, P.O. Box 72511, Egypt.
Saqer S AlotaibiDepartment of Biotechnology, College of Sciences, Taif University, P.O.Box 11099, Taif 21944, Saudi Arabia.ORCID https://orcid.org/0000-0002-6162-7953
Bashir LawalPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.ORCID https://orcid.org/0000-0003-0676-5875
Gaber El-Saber BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt.ORCID https://orcid.org/0000-0002-7817-425X
Carlos Adam Conte-JuniorCenter for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro 21941-598, Brazil.ORCID https://orcid.org/0000-0001-6133-5080
Mustansiriyah University · IQTaif University · SATanta University · EGBeni-Suef University · EGDamanhour University · EGSouth Valley University · EGTaipei Medical University · TWUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced liver injury (DILI) is the main cause of liver damage mediated by the excretion of toxic active drug metabolites. Omega-3 fatty acids and vitamin C have potent antioxidant, anti-inflammatory, and antiapoptotic effects that could offer protection against oxidative stress and liver damage. This study evaluated the hepatoprotective effect of omega-3 and vitamin C alone as well as in a combined form in methotrexate- (MTX-) induced acute liver injury in mice. Male ICR mice of seven groups (7 mice per group) were used. Groups 1 (control group) and 2 (MTX) received 0.9% saline/day (po) for 9 days. Groups 3 and 4 received 100 and 200 mg/kg bw/day omega-3 (po), respectively, for 9 days. Groups 5 and 6 received 100 and 200 mg/kg bw/day vitamin C (po), respectively, for 9 days, while group 7 received omega-3 (100 mg/kg bw/day) and vitamin C (100 mg/kg bw/day) (po) for 9 days. All animals in groups 2 to 7 received 20 mg/kg/day MTX (I.P.) once on the 10

Indexed as

Chemical and Drug Induced Liver InjuryFatty Acids, Omega-3AnimalsAntioxidantsAscorbic AcidGlutathioneMaleMethotrexateMiceMice, Inbred ICRMolecular Docking SimulationOxidative StressVitaminsAntioxidantsAscorbic AcidFatty Acids, Omega-3GlutathioneMethotrexateVitamins

Identifiers

PMID35496049
PMCPMC9045995
OpenAlexW4224210431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.